OKS for Sensory Neglect

Beth Israel Deaconess Medical Center, Boston, MA
Sensory Neglect+2 More ConditionsOKS - Device
Eligibility
21 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help researchers understand how optokinetic stimulation (a therapy involving moving patterns) can help patients with hemispatial neglect (a disorder where patients have difficulty attending to objects on the left side following a stroke).

Eligible Conditions
  • Sensory Neglect
  • Hemisensory Neglect
  • Hemispatial Neglect

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: After 1 hour of OKS

Hour 1
Change in Hemispatial neglect scores
Changes in secondary hemispatial neglect scores
Effect of OKS on gait
Effect of OKS on vision

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

4 Treatment Groups

OKS and gait
1 of 4
Optimization of OKS
1 of 4
Effect of repetitive stimulation
1 of 4
Safety and efficacy study
1 of 4

Experimental Treatment

12 Total Participants · 4 Treatment Groups

Primary Treatment: OKS · No Placebo Group · N/A

OKS and gait
Device
Experimental Group · 1 Intervention: OKS · Intervention Types: Device
Optimization of OKS
Device
Experimental Group · 1 Intervention: OKS · Intervention Types: Device
Effect of repetitive stimulation
Device
Experimental Group · 1 Intervention: OKS · Intervention Types: Device
Safety and efficacy study
Device
Experimental Group · 1 Intervention: OKS · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OKS
2018
N/A
~20

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: after 1 hour of oks

Who is running the clinical trial?

Johns Hopkins UniversityOTHER
2,115 Previous Clinical Trials
32,578,757 Total Patients Enrolled
National Eye Institute (NEI)NIH
523 Previous Clinical Trials
1,075,916 Total Patients Enrolled
Beth Israel Deaconess Medical CenterLead Sponsor
791 Previous Clinical Trials
849,522 Total Patients Enrolled
Chun Lim, MDPrincipal Investigator - Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center-Departmet of Neurology

Eligibility Criteria

Age 21 - 80 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is there an opportunity to participate in this research endeavor?

"To register for this clinical trial, participants must suffer from sensory neglect and be within the age range of 21 to 80. The research team is looking for a total of 52 individuals to take part in the study." - Anonymous Online Contributor

Unverified Answer

Does this research include individuals aged 70 and above?

"The parameters for inclusion in this study necessitate that individuals must be between 21 and 80 years old. There are also 2 trials specifically designed for minors and 12 clinical studies available to people aged 65 or above." - Anonymous Online Contributor

Unverified Answer

Is enrollment available for this clinical experiment?

"According to the listing on clinicaltrials.gov, this medical study is actively recruiting participants and was originally posted in May 2018 with its latest update occurring on March 8th 2022." - Anonymous Online Contributor

Unverified Answer

To what extent has enrollment for this clinical trial been successful?

"Affirmative. The resource on clinicaltrials.gov supports that this experiment, which was created on May 1st 2018, is actively recruiting volunteers. 52 individuals are needed to be enlisted from a single medical establishment." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.